Covered recipient · General Payments record
JENNIE ELIZABETH MARTINI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2024
$801.39
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $658.56 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $237.68 | 12 |
| Lilly USA, LLC | $136.13 | 9 |
| Novo Nordisk AS | $131.80 | 7 |
| GlaxoSmithKline, LLC. | $52.66 | 3 |
| Acerta Pharma LLC | $48.07 | 3 |
| Exact Sciences Corporation | $34.60 | 2 |
| PFIZER INC. | $17.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.43 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600639 | CMS |
| ABBVIE INC. | $20.10 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600641 | CMS |
| ABBVIE INC. | $32.05 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600643 | CMS |
| ABBVIE INC. | $10.04 | 02/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600645 | CMS |
| ABBVIE INC. | $19.12 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600647 | CMS |
| ABBVIE INC. | $29.30 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600649 | CMS |
| ABBVIE INC. | $10.30 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600651 | CMS |
| ABBVIE INC. | $32.04 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600653 | CMS |
| ABBVIE INC. | $16.52 | 06/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600655 | CMS |
| ABBVIE INC. | $14.87 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600657 | CMS |
| ABBVIE INC. | $7.03 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600659 | CMS |
| ABBVIE INC. | $28.88 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107600661 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.94 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104769378 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.66 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104528878 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.47 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105826929 | CMS |
| Exact Sciences Corporation | $17.22 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114453134 | CMS |
| Exact Sciences Corporation | $17.38 | 10/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114453139 | CMS |
| GlaxoSmithKline, LLC. | $18.92 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116591421 | CMS |
| GlaxoSmithKline, LLC. | $17.94 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116284516 | CMS |
| GlaxoSmithKline, LLC. | $15.80 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115731603 | CMS |
| Lilly USA, LLC | $15.25 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135695890 | CMS |
| Lilly USA, LLC | $5.93 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135714052 | CMS |
| Lilly USA, LLC | $3.91 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135695276 | CMS |
| Lilly USA, LLC | $25.00 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135655519 | CMS |
| Lilly USA, LLC | $26.65 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135698012 | CMS |
| Lilly USA, LLC | $18.19 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135709566 | CMS |
| Lilly USA, LLC | $18.56 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135698010 | CMS |
| Lilly USA, LLC | $7.55 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135643584 | CMS |
| Lilly USA, LLC | $15.09 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135714054 | CMS |
| Novo Nordisk Inc | $19.39 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100424652 | CMS |
| Novo Nordisk Inc | $16.62 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100334438 | CMS |
| Novo Nordisk Inc | $19.82 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100588499 | CMS |
| Novo Nordisk Inc | $16.46 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100583580 | CMS |
| Novo Nordisk Inc | $18.16 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100591430 | CMS |
| Novo Nordisk Inc | $20.69 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100246163 | CMS |
| Novo Nordisk Inc | $20.66 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100331422 | CMS |
| PFIZER INC. | $17.62 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131833120 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.